Prognostic value of pentraxin 3 in patients with chronic heart failure

International Journal of Cardiology

Volumn 130, Issue 1, 2008, Pages 19-22

  Kotooka, Norihiko ^a   Inoue, Teruo ^a   Aoki, Shigehisa ^a   Anan, Mayumi ^a   Komoda, Hiroshi ^a   Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Chronic heart failure; Inflammation; Pentraxin 3; Prognosis

Indexed keywords

BIOLOGICAL MARKER; PENTRAXIN 3;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PRIORITY JOURNAL; PROGNOSIS;

C-REACTIVE PROTEIN; CHRONIC DISEASE; HEART FAILURE; HUMANS; PROGNOSIS; SERUM AMYLOID P-COMPONENT;

EID: 53549094954     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.168     Document Type: Article

References (19)

1. Garlanda C., Bottazzi B., Bastone A., et al. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23 (2005) 337-366
2. Inoue K., Sugiyama A., Reid P.C., et al. Establishment of high sensitivity plasma assay nor human pentraxin3 as a marker for unstable angina pectolis. Arterioscler Thromb Vasc Viol 27 (2007) 161-167
3. Stefan D.A., and Stephan H. Inflammatory mediators in chronic heart failure: an overview. Heart 90 (2004) 464-470
4. Torre-Amione G., Kapadia S., Benedict C., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
5. Munger M.A., Johnson B., Amber I.J., et al. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77 (1996) 723-727
6. Roig E., Orus J., Pare C., et al. Interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 82 (1998) 688-690
7. Orus J., Roig E., Perez-Villa F., et al. Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant 19 (2000) 419-425
8. Shioi T., Matsumori A., Kihara Y., et al. Increased expression of interleukin-1β and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res 81 (1997) 664-671
9. Levine B., Kalman J., Mayer L., et al. Elevated circulation levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
10. Matsumori A. Anti-inflammatory therapy for heart failure. Curr Opin Pharmacol 4 (2004) 171-176
11. Yin W.H., Chen J.W., Jen H.L., et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 147 (2004) 931-938
12. Pepys M.B., and Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 111 (2003) 1805-1812
13. Griselli M., Herbert J., Hutchinson W.L., et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 190 (1999) 1733-1739
14. Bottazzi B., Vouret-Craviari V., Bastone A., et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyroid P component. J Biol Chem 272 (1997) 32817-32823
15. Nauta A.J., Bottazzi B., Mantovani A., et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol 33 (2003) 465-473
16. Latini R., Maggioni A.P., Peri G., et al. Lipid Assessment Trial Italian Network (LATIN) Investigators. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 110 (2004) 2349-2354
17. Pliquett R.U., Cornish K.G., Peuler J.D., et al. Simvastatin normalizes autonomic neural control in experimental heart failure. Circulation 107 (2003) 2493-2498
18. Node K., Fujita M., Kitakaze M., et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 108 (2003) 839-843
19. Morikawa S., Takabe W., Mataki C., et al. Global analysis of RNA expression profile in human vascular cells treated with statins. J Atheroscler Thromb 11 (2004) 62-72